Trial intelligence / Profile preview

Byetta effect on cerebral blood flow in stroke

NCT02829502Phase 2Unknown

Start
Aug 2016
Primary completion
Aug 2023
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of exenatide in ischemic stroke. Status: unknown.

02

Drugs

exenatide
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT02829502.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02829502.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call